DENVILLE, N.J., January 7, 2008 -- Lantis Laser Inc. (LLSR:PK - News) (http://www.lantislaser.com) reports that researchers have shown that optical coherence tomography (OCT), a novel light-based bio-medical imaging technology, has the ability to characterize the root canal walls during therapy. The research by Dr Hagay Shemesh et al at the Academic Centre for Dentistry in Amsterdam, The Netherlands was published as the feature article in the Journal of Endodontics November 2007 issue. Using a real-time chairside OCT imaging system, dentists could view the root canal after preparation to ensure that possible causes of treatment failure have been eliminated as much as possible.
“ This is a very exciting and significant expansion of the application of OCT in dentistry, ” commented Dr Craig Gimbel, Vice-President Clinical Affairs at Lantis. “ Currently dentists have no means of viewing the canal in detail and this research clearly shows that OCT could become the gold standard for characterizing perforations, cracks or other imperfections in the canal that contribute to treatment failure.”
The paper clearly demonstrated the ability of OCT to image root canal walls after endodontic preparation and to correlate the OCT images with histologic sections to validate the integrity of the OCT imaging system. The conclusion of the study was that OCT proved to be reliable method to image root canal tissue in a non-destructive way.
Lantis is currently preparing its OCT Dental Imaging System for deployment in clinical use. In order to commercialise the endodontic application Lantis is designing and building the special rotary scanner that is required for the endodontic application. Lantis intends to work closely with Dr Shemesh and ACTA to fully realize the potential of OCT in endodontics.
Stan Baron, President and CEO of Lantis said, “ This research shows that the application of OCT in dentistry enables dentists to obtain views of tissue that have been hitherto unobtainable. Once in the hands of dentists many other applications, apart from the early detection of oral diseases such as decay, will become evident and show that OCT will become indispensable in the dental office as it raises imaging and diagnostics to a new level.”
About Landis Laser
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 development and plans to launch the OCT Dental Imaging System(TM) in the third quarter of 2008. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory and LightLab Imaging. OCT was invented in the early 1990's at the Massachusetts Institute of Technology and is currently being commercialized by Carl Zeiss Meditec, Inc. in ophthalmology and by LightLab Imaging for cardiovascular imaging.
To find out more about Lantis Laser (LLSR: PK), visit our website at www.lantislaser.com
Forward-Looking Statements:
Certain statements in this press release, including statements regarding the anticipated development and expansion of Lantis' business, and the intent, belief or current expectations of Lantis, its directors or its officers, are forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.
CONTACT INFORMATION
Corporate Inquiries
Stan Baron, President & CEO
Telephone: (203) 300-7622
sbaron@lantislaser.com
Investor Relations
AGORACOM Investor Relations
http://www.agoracom.com/IR/lantislaser
llsr@agoracom.com
